JO ANNE MILLER: Open Payments
NPI 1740514926 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 20 payments from 16 companies in 2025. Trend: 2023 $176 · 2024 $475 · 2025 $387
Food & beverage: $387
| Company | Payments | Amount |
|---|---|---|
| ARRAY BIOPHARMA INC | 2 | $46 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Deciphera Pharmaceuticals Inc. | 1 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| ABBVIE INC. | 2 | $30 |
| Celgene Corporation | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| PharmaEssentia USA Corporation | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| GENZYME CORPORATION | 1 | $19 |
Products named: OJJAARA, QINLOCK, IMFINZI, EPKINLY, REBLOZYL, BRAFTOVI, KEYTRUDA, BESREMI.
Industry payments across AL — which companies pay providers there.
